Research

Energy balance

1,260,969 (8.5%) Black people and 4,989,919 (4.7%) non-Black people had ≥CKD stage 3 according to the 2021 CKD-EPI formula.

Practitioners should consider the impact of the new eGFR formula on the classification of CKD in patients when prescribing antiobesity medications.

StrongSupportsmedium confidence
Applying the 2021 CKD-EPI formula, 1,260,969 (8.5%) Black people and 4,989,919 (4.7%) non-Black people had ≥CKD stage 3.
Babak J. Orandi et al. · Obesity · 2022

Why this rating

Based on the use of NHANES cohort study data.

Source

Impact of refitted <scp>race‐free eGFR</scp> formula on obesity pharmacotherapy options

Babak J. Orandi et al. · Obesity · 2022

DOI 10.1002/oby.23542

cohort · n=126127322Cited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →